Australia and Asia Pacific offer international biotech industry a wealth of clinical trial and costs benefits
wardsauto.com -

SAN FRANCISCO, Jan. 9, 2018 /PRNewswire/ -- Australia and the Asia Pacific are fast becoming the destination of choice for the over US$140 billion international biotech industry1, with considerable research incentives, supportive regulatory environments and affordable trial costs...

Loading...

Related Articles